Tag: PKU gene therapy FDA approval status 2024
PKU Gene Therapy 2024: Complete Guide to FDA Approval Status, Clinical Trial Results, Cost Estimates, Insurance Coverage & Rare Metabolic Disorder Pipeline (2024 Update)
Per 2024 FDA, CDC, and National Organization for Rare Disorders (NORD) data, 18,800 U.S. phenylketonuria (PKU) patients rely on restrictive lifelong dietary care, with 3 lead gene therapy candidates in late-phase trials as of this October 2024 buying guide. This resource compares Premium vs Counterfeit Models of unvetted overseas PKU gene therapies to help patients